A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19

BACKGROUND: There is an urgent need for treatments of mild or moderate COVID-19 in an outpatient setting. METHODS: A randomized double-blind placebo-controlled clinical trial in 36 centers in the U.S. between August 2020 and February 2021 investigated the safety and effectiveness of oral nitazoxanid...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossignol, Jean-François, Bardin, Matthew C., Fulgencio, Jessica, Mogelnicki, Dena, Bréchot, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883002/
https://www.ncbi.nlm.nih.gov/pubmed/35237748
http://dx.doi.org/10.1016/j.eclinm.2022.101310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883002/
https://www.ncbi.nlm.nih.gov/pubmed/35237748
http://dx.doi.org/10.1016/j.eclinm.2022.101310

Ejemplares similares